SRPT Q1 2019 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$87M+34.7% YoY

Gross Profit

$75M86.1% margin

Operating Income

-$76M-87.8% margin

Net Income

-$77M-88.1% margin

EPS (Diluted)

$-1.07

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

-$146M

Free Cash Flow

-$163M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$615M

Stockholders' Equity

$1.3B

Cash & Equivalents

$732M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$65M	+34.7%
Gross Profit	$75M	$59M	+27.0%
Operating Income	-$76M	-$31M	-148.5%
Net Income	-$77M	-$35M	-116.7%